Pharm Tech Minutes 2015.02.24

From IHE Wiki
Revision as of 08:36, 24 February 2015 by Costateixeira (talk | contribs)
Jump to navigation Jump to search

Meeting details

Tuesday, 24 February 2015, 10:00 CET

Location : Villa Modigliani

  • PHARMA : salon Nabis
  • PCC : salon Baroques
  • QRPH : salon Fauves-Expressionnistes
  • ITI : salon Réalistes

WebEx details:

https://phastinternational.webex.com/phastinternational-en/j.php?MTID=m63d78e6130dbb440d12caf48205c9806

Meeting number: 958 500 452


JOIN BY PHONE

  • +33 17091 8646 France toll
  • 0800-9-19312 France toll free

Call-in Numbers: Global Call-in numbers

Access code: 958 500 452

10:00 - 10:15 Welcome

  • Participants
  • Michael Tan
  • Jose Costa Teixeira
  • Jürgen Brandstätter
  • Leonidas Tzimis
  • Simon Letellier
  • Jacqueline Surugue
  • Stephane Spahni
  • Isabelle Gibaud
  • Review and Approve Agenda
  • Approved
  • Approval of minutes of Technical Committee TCon on Jan 29
  • Approved


10:15 - 10:45 HMW Review, CMPD and HMW alignment with FHIR

Overview of the issues that we expected to find:

  • Functional model divergences (not really big, maybe no even significant, but must be analyzed)
  • Data model (mapping FHIR - CDA - V2) - this has already shown some gaps.

Next steps:

  • Align with John Moehrke about a mechanism for collaboration.
  • Meanwhile, we can start providing some content for discussions with HL7 (on behalf of this mechanism).
    • Juergen will create a doodle for the next discussion.


12:00 - 13:00 Lunch

13:00 - 13:30 Preparation ITI, PCC, PHARM meeting

  • CP for duration of treatment
    • Juergen presents the issue in the Duration of Treatment. in IHE, it is mandatory, even if null flavour.
  • Side question: Dosage instructions are including Route and Approach site. The problem with reviewing that is that the implementations have implemented it as is. This issue will be discussed later.
  • Resolution: CP makes sense as is, and it solves the problem without a need to discuss with PCC. Juergen will continue with this.
  • Question on the Repeat/Duration: "Get a box of medication, get as many boxes as needed for 1 year" - is this repeat?
    • This issue can be resolved by the "duration of treatment", since each dispense is a partial dispense for a prescription, not a repeated dispense.

The issue is that sometimes we need to limit the amount of drug dispensed each time.

Leonidas: This is sometimes limited not by the amount, but by the time that is allowed to dispense Jacqueline: In France, the renewal possibility is linked to the type of drug. Some drugs may be renewed automatically, others cannot be renewed without a prescription. Action Item: Use Cases should be created to present the need for implementing any additional parameter like "maximum amount/time to dispense each time" Decision: Some text will be added to the DIS profile to clarify the use of Repeat Action item: A use case will be created to see if it breaks the current implementation (Stéphane)


13:30 - 15:00 Supply of Healthcare Products

  • Process and method - White paper structure
    • Discuss with HL7 and ISO
  • Status and scope of White Paper
    • Discuss with IHE, HL7 and ISO


15:00 - 15:15 Break

15:15 - 16:15 Healthcare Products Catalogue

16:15 - 17:00 CPs on Community Pharmacy profiles

17:00 - 18:00 Medication Data overview

  • Overview of terms and concepts
  • Medication data collection
  • Defining next steps
  • Proposal
  • Defining next steps


18:00 Adjourn

Pharmacy Technical Committee